Johnson & Johnson (NYSE:JNJ)

122.84
Delayed Data
As of Jun 22
 +1.39 / +1.14%
Today’s Change
118.62
Today|||52-Week Range
148.32
-12.08%
Year-to-Date
52-Week Company Lows
Jun 21 / GuruFocus News - Paid Partner Content
Kentucky sues Walgreens for its role in the opioid crisis
Jun 14 / CNNMoney.com
MedTech Overcomes Policy Hurdles, Long-Term Prospects Bright
Jun 15 / Zacks.com - Paid Partner Content
Why Fox Is the Top Stock to Watch for 2026 North American World Cup
Jun 13 / Zacks.com - Paid Partner Content
Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III
Jun 15 / Zacks.com - Paid Partner Content
J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit
Jun 13 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod
Jun 15 / Zacks.com - Paid Partner Content
Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate
Jun 12 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and...
Jun 15 / Zacks.com - Paid Partner Content
Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label
Jun 12 / Zacks.com - Paid Partner Content
Growth & Income Buys | Johnson & Johnson and International Paper
Jun 14 / Zacks.com - Paid Partner Content
Alzheimer's Research Stumbles Again: What's the Road Ahead?
Jun 12 / Zacks.com - Paid Partner Content
Medical Device Industry Outlook - June 2018
Jun 14 / Zacks.com - Paid Partner Content
Stryker Likely to Acquire Boston Scientific, Shares Down
Jun 12 / Zacks.com - Paid Partner Content